Healthy men who experienced psychotic symptoms after THC showed greater hippocampal activation during a learning task even under placebo, suggesting pre-existing brain differences that predict THC sensitivity.
Read this if you want to understand why some people experience psychotic effects from cannabis while most do not.
39% of healthy men developed transient psychotic symptoms from 10 mg THC
What the researchers found
Researchers gave 36 healthy men either 10 mg oral THC or placebo in a randomized crossover design and measured both psychotic symptoms and brain activity during a verbal learning task using fMRI. They then divided participants into those who experienced transient psychotic symptoms after THC (14 men) and those who did not (22 men).
The key finding was visible before any THC was given. Under placebo conditions, the group that would later develop psychotic symptoms from THC already showed significantly greater engagement of the left hippocampus during verbal encoding compared to the non-sensitive group. This pre-existing difference in hippocampal activation was directly correlated with the severity of psychotic symptoms later induced by THC.
Importantly, this pattern was specific to psychosis sensitivity. When the researchers created subgroups based on anxiety sensitivity to THC instead, no such hippocampal difference was found, suggesting this is a specific marker for psychotic vulnerability rather than general THC sensitivity.
Why it matters
Identifying who is at risk for psychotic reactions to cannabis before they happen is one of the most important unsolved problems in cannabis research. This study suggests that hippocampal activation during learning could serve as a biomarker, potentially allowing identification of vulnerable individuals before they experience adverse effects.
The numbers in context
36 healthy males studied. 14 (39%) experienced transient psychotic symptoms from THC. 22 did not. Significantly greater left hippocampal activation under placebo in the sensitive group (p < 0.001). Correlation between hippocampal activation and symptom severity: Spearman's rho = 0.44, p = 0.008. Finding survived leave-one-out analysis.
How the study worked
This was a pseudo-randomized, double-blind, repeated-measures, within-subject crossover study. Thirty-six healthy males received 10 mg oral THC and placebo on separate occasions. Psychopathological assessments and fMRI during a verbal learning task were performed under both conditions. Participants were classified into THC-psychosis-sensitive (n=14) and non-sensitive (n=22) groups.
What this study cannot tell us
The sample included only healthy men, and findings may differ in women or in clinical populations. The classification into sensitive and non-sensitive groups was based on a single THC exposure. The study cannot determine whether the hippocampal difference is genetic, developmental, or environmental in origin. Sample sizes within subgroups were relatively small (14 and 22).
How to read the evidence
This is a well-designed randomized crossover study with fMRI, providing moderate evidence for a neural biomarker of THC psychosis sensitivity.
When this study was published
Published in 2018. Research on biomarkers for cannabis psychosis sensitivity continues.
The bigger picture
This study suggests that susceptibility to THC-induced psychosis is not random but reflects pre-existing differences in brain function. The hippocampus is one of the brain regions richest in cannabinoid receptors, and its role in memory and pattern recognition may make altered hippocampal function a vulnerability factor for psychotic experiences when cannabinoid signaling is disrupted.
Questions still open
- Could hippocampal activation testing be developed into a practical screening tool for cannabis psychosis risk? What causes the pre-existing hippocampal hyperactivation in sensitive individuals? Does this marker also predict vulnerability to cannabis-associated psychotic disorders with chronic use?
Common questions
Can we predict who will get psychotic effects from cannabis?
Is it common to experience psychotic symptoms from THC?
Read the original research
Increased hippocampal engagement during learning as a marker of sensitivity to psychotomimetic effects of δ-9-THC.
Psychological medicine, 48(16), 2748-2756
Citation
Bhattacharyya, Sagnik; Sainsbury, Thomas; Allen, Paul; Nosarti, Chiara; Atakan, Zerrin; Giampietro, Vincent; Brammer, Michael; McGuire, P K. (2018). Increased hippocampal engagement during learning as a marker of sensitivity to psychotomimetic effects of δ-9-THC.. Psychological medicine, 48(16), 2748-2756. https://doi.org/10.1017/S0033291718000387
Explore the wider topic
- How THC Affects Your Amygdala: The Brain's Threat Detector and Cannabis
- The Anandamide Connection: Your Body's Natural Bliss Molecule
- How Long for Cannabinoid Receptors to Return to Normal
- Cannabis and the Developing Brain: What Every Teenager (and Parent) Should Know
- Why Can't I Enjoy Anything Without Weed? The Science Behind It
- Dopamine Recovery After Quitting Weed: What the Science Says
- The Endocannabinoid System Explained Simply: What It Does and Why It Matters
- Your Endocannabinoid System Explained: Why Withdrawal Happens
- Your Nervous System After Quitting Weed: Fight or Flight
- Using Weed Under 18: What It Does to Your Developing Brain
- What THC Does to Your Brain: Why Withdrawal Happens
- THC and Your Prefrontal Cortex: What Cannabis Does to Your Decision-Making Brain
- Weed, Cortisol, and Stress: What Cannabis Does to Your Stress Hormones
- Weed and Memory: What the Science Says About THC and Your Hippocampus
- Weed and Motivation: Is Amotivational Syndrome Real?
- Weed and Your Nervous System: What THC Actually Does to Your Brain and Body
- How Weed Rewires Your Reward System (And How to Reset It)